agfa healthcare uk limited
agfa healthcare uk limited Company Information
Company Number
06317215
Next Accounts
164 days late
Shareholders
agfa nv
Group Structure
View All
Industry
Other information technology and computer service activities
+1Registered Address
515 coldhams lane, cambridge, CB1 3JS
Website
www.agfa.comagfa healthcare uk limited Estimated Valuation
Pomanda estimates the enterprise value of AGFA HEALTHCARE UK LIMITED at £9.3m based on a Turnover of £14.3m and 0.65x industry multiple (adjusted for size and gross margin).
agfa healthcare uk limited Estimated Valuation
Pomanda estimates the enterprise value of AGFA HEALTHCARE UK LIMITED at £0 based on an EBITDA of £-383k and a 4.7x industry multiple (adjusted for size and gross margin).
agfa healthcare uk limited Estimated Valuation
Pomanda estimates the enterprise value of AGFA HEALTHCARE UK LIMITED at £27.7m based on Net Assets of £12.1m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Agfa Healthcare Uk Limited Overview
Agfa Healthcare Uk Limited is a live company located in cambridge, CB1 3JS with a Companies House number of 06317215. It operates in the other information technology service activities sector, SIC Code 62090. Founded in July 2007, it's largest shareholder is agfa nv with a 100% stake. Agfa Healthcare Uk Limited is a established, mid sized company, Pomanda has estimated its turnover at £14.3m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Agfa Healthcare Uk Limited Health Check
Pomanda's financial health check has awarded Agfa Healthcare Uk Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
7 Weak
Size
annual sales of £14.3m, make it larger than the average company (£3.8m)
£14.3m - Agfa Healthcare Uk Limited
£3.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 26%, show it is growing at a faster rate (5.3%)
26% - Agfa Healthcare Uk Limited
5.3% - Industry AVG
Production
with a gross margin of 26.6%, this company has a higher cost of product (44.3%)
26.6% - Agfa Healthcare Uk Limited
44.3% - Industry AVG
Profitability
an operating margin of -3.8% make it less profitable than the average company (5.4%)
-3.8% - Agfa Healthcare Uk Limited
5.4% - Industry AVG
Employees
with 35 employees, this is similar to the industry average (30)
35 - Agfa Healthcare Uk Limited
30 - Industry AVG
Pay Structure
on an average salary of £64.8k, the company has a higher pay structure (£48k)
£64.8k - Agfa Healthcare Uk Limited
£48k - Industry AVG
Efficiency
resulting in sales per employee of £409.4k, this is more efficient (£110.3k)
£409.4k - Agfa Healthcare Uk Limited
£110.3k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is later than average (39 days)
50 days - Agfa Healthcare Uk Limited
39 days - Industry AVG
Creditor Days
its suppliers are paid after 17 days, this is quicker than average (26 days)
17 days - Agfa Healthcare Uk Limited
26 days - Industry AVG
Stock Days
it holds stock equivalent to 53 days, this is more than average (15 days)
53 days - Agfa Healthcare Uk Limited
15 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (61 weeks)
0 weeks - Agfa Healthcare Uk Limited
61 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 34.3%, this is a lower level of debt than the average (45.1%)
34.3% - Agfa Healthcare Uk Limited
45.1% - Industry AVG
AGFA HEALTHCARE UK LIMITED financials
Agfa Healthcare Uk Limited's latest turnover from December 2022 is £14.3 million and the company has net assets of £12.1 million. According to their latest financial statements, Agfa Healthcare Uk Limited has 35 employees and maintains cash reserves of £1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 14,329,000 | 8,933,000 | 10,166,000 | 7,159,000 | 10,466,949 | 12,638,000 | 13,545,000 | 13,950,000 | 14,534,000 | 14,548,000 | 14,007,000 | 14,742,000 | 15,467,000 | 15,046,000 |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | 10,519,000 | 4,005,000 | 5,216,000 | 3,530,000 | 5,547,800 | 6,473,000 | 7,500,000 | 8,202,000 | 8,426,000 | 8,600,000 | 8,972,000 | 9,855,000 | 10,375,000 | 9,061,000 |
| Gross Profit | 3,810,000 | 4,928,000 | 4,950,000 | 3,629,000 | 4,919,149 | 6,165,000 | 6,045,000 | 5,748,000 | 6,108,000 | 5,948,000 | 5,035,000 | 4,887,000 | 5,092,000 | 5,985,000 |
| Admin Expenses | 4,357,000 | 5,303,000 | 4,329,000 | 2,692,000 | 7,390,209 | 5,933,000 | 5,715,000 | 5,087,000 | 4,697,000 | 5,493,000 | 4,730,000 | 9,604,000 | 5,264,000 | 5,482,000 |
| Operating Profit | -547,000 | -375,000 | 621,000 | 937,000 | -2,471,060 | 232,000 | 330,000 | 661,000 | 1,411,000 | 455,000 | 305,000 | -4,717,000 | -172,000 | 503,000 |
| Interest Payable | 2,000 | 5,000 | 4,000 | 4,000 | 4,036 | 6,000 | 8,000 | 12,000 | 10,000 | 6,000 | 73,000 | 14,000 | 8,000 | 147,000 |
| Interest Receivable | 19,000 | 59,000 | 50,943 | 19,000 | 33,000 | 31,000 | 31,000 | 19,000 | 8,000 | 19,000 | 9,000 | 5,000 | ||
| Pre-Tax Profit | -390,000 | -380,000 | 636,000 | 992,000 | -2,424,153 | 245,000 | 355,000 | 680,000 | 1,432,000 | 468,000 | 240,000 | -4,712,000 | -171,000 | 361,000 |
| Tax | 783,000 | -174,000 | -229,000 | -292,322 | -68,000 | -227,000 | -98,000 | -269,000 | -615,000 | 1,072,000 | -194,000 | 101,000 | ||
| Profit After Tax | -390,000 | 403,000 | 462,000 | 763,000 | -2,716,475 | 177,000 | 128,000 | 680,000 | 1,334,000 | 199,000 | -375,000 | -3,640,000 | -365,000 | 462,000 |
| Dividends Paid | ||||||||||||||
| Retained Profit | -390,000 | 403,000 | 462,000 | 763,000 | -2,716,475 | 177,000 | 128,000 | 680,000 | 1,334,000 | 199,000 | -375,000 | -3,640,000 | -365,000 | 462,000 |
| Employee Costs | 2,268,000 | 10,738,000 | 5,060,000 | 3,335,000 | 5,497,284 | 7,202,000 | 7,292,000 | 6,684,000 | 6,178,000 | 6,204,000 | 5,378,000 | 10,181,000 | 5,863,000 | 5,578,000 |
| Number Of Employees | 35 | 33 | 32 | 33 | 75 | 96 | 95 | 96 | 97 | 101 | 94 | 92 | 87 | 79 |
| EBITDA* | -383,000 | -213,000 | 824,000 | 1,102,000 | -2,404,807 | 259,000 | 356,000 | 677,000 | 1,411,000 | 1,232,000 | 1,109,000 | -3,866,000 | 713,000 | 1,341,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 261,000 | 352,000 | 176,000 | 268,000 | 146,922 | 14,000 | 38,000 | 49,000 | 4,000 | 9,000 | 45,000 | 128,000 | 177,000 | |
| Intangible Assets | 6,690,000 | 6,690,000 | 6,690,000 | 6,690,000 | 2,751,000 | 3,519,000 | 4,287,000 | 5,055,000 | 5,824,000 | |||||
| Investments & Other | ||||||||||||||
| Debtors (Due After 1 year) | 185,000 | 408,000 | 786,000 | |||||||||||
| Total Fixed Assets | 261,000 | 352,000 | 176,000 | 268,000 | 146,922 | 6,704,000 | 6,728,000 | 6,739,000 | 6,694,000 | 2,936,000 | 3,936,000 | 5,118,000 | 5,183,000 | 6,001,000 |
| Stock & work in progress | 1,545,000 | 887,000 | 750,000 | 635,000 | 481,461 | |||||||||
| Trade Debtors | 1,975,000 | 3,097,000 | 3,341,000 | 1,272,000 | 1,772,415 | 2,993,000 | 2,704,000 | 3,872,000 | 4,600,000 | 4,613,000 | 7,116,000 | 3,245,000 | 4,815,000 | |
| Group Debtors | 12,720,000 | 11,101,000 | 11,955,000 | 11,818,000 | 13,600,523 | 11,655,000 | 12,586,000 | 8,279,000 | 8,650,000 | 9,365,000 | 3,604,000 | 5,631,000 | 8,967,000 | 7,969,000 |
| Misc Debtors | 1,862,000 | 2,119,000 | 697,000 | 810,000 | 145,971 | 237,000 | 223,000 | 313,000 | 384,000 | 331,000 | 3,559,000 | 760,000 | 351,000 | 310,000 |
| Cash | 1,000 | 1,000 | 2,000 | 6,000 | ||||||||||
| misc current assets | ||||||||||||||
| total current assets | 18,103,000 | 17,205,000 | 16,745,000 | 14,535,000 | 16,000,370 | 14,885,000 | 15,513,000 | 12,464,000 | 13,634,000 | 14,315,000 | 14,279,000 | 9,636,000 | 14,133,000 | 8,279,000 |
| total assets | 18,364,000 | 17,557,000 | 16,921,000 | 14,803,000 | 16,147,292 | 21,589,000 | 22,241,000 | 19,203,000 | 20,328,000 | 17,251,000 | 18,215,000 | 14,754,000 | 19,316,000 | 14,280,000 |
| Bank overdraft | 10,437 | |||||||||||||
| Bank loan | ||||||||||||||
| Trade Creditors | 493,000 | 853,000 | 1,360,000 | 3,135,000 | 405,011 | 1,360,000 | 914,000 | 1,012,000 | 768,000 | 1,124,000 | 964,000 | 777,000 | 448,000 | 777,000 |
| Group/Directors Accounts | 2,461,000 | 1,564,000 | 2,077,000 | 1,354,323 | 5,131,000 | 6,411,000 | 3,691,000 | 5,649,000 | 6,624,000 | 8,482,000 | 6,643,000 | 9,367,000 | 5,057,000 | |
| other short term finances | ||||||||||||||
| hp & lease commitments | 56,000 | 68,000 | 78,000 | |||||||||||
| other current liabilities | 3,214,000 | 2,499,000 | 1,276,000 | 3,521,566 | 1,478,000 | 2,006,000 | 1,230,000 | 1,321,000 | 2,186,000 | 1,651,000 | 4,341,000 | 2,867,000 | 1,447,000 | |
| total current liabilities | 6,224,000 | 4,984,000 | 4,791,000 | 3,135,000 | 5,291,337 | 7,969,000 | 8,843,000 | 5,933,000 | 7,738,000 | 9,934,000 | 11,097,000 | 11,761,000 | 12,682,000 | 7,281,000 |
| loans | ||||||||||||||
| hp & lease commitments | 73,000 | 116,000 | 76,000 | 76,000 | ||||||||||
| Accruals and Deferred Income | ||||||||||||||
| other liabilities | ||||||||||||||
| provisions | 27,430 | 75,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 31,000 | 31,000 | ||||
| total long term liabilities | 73,000 | 116,000 | 76,000 | 76,000 | 27,430 | 75,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 31,000 | 31,000 |
| total liabilities | 6,297,000 | 5,100,000 | 4,867,000 | 3,211,000 | 5,318,767 | 8,044,000 | 8,873,000 | 5,963,000 | 7,768,000 | 9,964,000 | 11,127,000 | 11,791,000 | 12,713,000 | 7,312,000 |
| net assets | 12,067,000 | 12,457,000 | 12,054,000 | 11,592,000 | 10,828,525 | 13,545,000 | 13,368,000 | 13,240,000 | 12,560,000 | 7,287,000 | 7,088,000 | 2,963,000 | 6,603,000 | 6,968,000 |
| total shareholders funds | 12,067,000 | 12,457,000 | 12,054,000 | 11,592,000 | 10,828,525 | 13,545,000 | 13,368,000 | 13,240,000 | 12,560,000 | 7,287,000 | 7,088,000 | 2,963,000 | 6,603,000 | 6,968,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -547,000 | -375,000 | 621,000 | 937,000 | -2,471,060 | 232,000 | 330,000 | 661,000 | 1,411,000 | 455,000 | 305,000 | -4,717,000 | -172,000 | 503,000 |
| Depreciation | 164,000 | 162,000 | 203,000 | 165,000 | 62,826 | 27,000 | 26,000 | 16,000 | 9,000 | 36,000 | 83,000 | 116,000 | 70,000 | |
| Amortisation | 3,427 | 768,000 | 768,000 | 768,000 | 769,000 | 768,000 | ||||||||
| Tax | 783,000 | -174,000 | -229,000 | -292,322 | -68,000 | -227,000 | -98,000 | -269,000 | -615,000 | 1,072,000 | -194,000 | 101,000 | ||
| Stock | 658,000 | 137,000 | 115,000 | 153,539 | 481,461 | |||||||||
| Debtors | 240,000 | 324,000 | 2,093,000 | -1,618,909 | 633,909 | -628,000 | 3,049,000 | -1,170,000 | -860,000 | -193,000 | 4,265,000 | -3,711,000 | 5,854,000 | 8,279,000 |
| Creditors | -360,000 | -507,000 | -1,775,000 | 2,729,989 | -954,989 | 446,000 | -98,000 | 244,000 | -356,000 | 160,000 | 187,000 | 329,000 | -329,000 | 777,000 |
| Accruals and Deferred Income | 715,000 | 1,223,000 | 1,276,000 | -3,521,566 | 2,043,566 | -528,000 | 776,000 | -91,000 | -865,000 | 535,000 | -2,690,000 | 1,474,000 | 1,420,000 | 1,447,000 |
| Deferred Taxes & Provisions | -27,430 | -47,570 | 45,000 | -1,000 | 31,000 | |||||||||
| Cash flow from operations | -926,000 | 825,000 | -2,057,000 | 1,519,363 | -2,771,492 | 782,000 | -2,242,000 | 2,000,000 | 952,000 | 1,851,000 | -6,274,000 | 2,719,000 | -4,244,000 | -4,582,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | ||||||||||||||
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | ||||||||||||||
| Group/Directors Accounts | 897,000 | -513,000 | 2,077,000 | -1,354,323 | -3,776,677 | -1,280,000 | 2,720,000 | -1,958,000 | -975,000 | -1,858,000 | 1,839,000 | -2,724,000 | 4,310,000 | 5,057,000 |
| Other Short Term Loans | ||||||||||||||
| Long term loans | ||||||||||||||
| Hire Purchase and Lease Commitments | -55,000 | 30,000 | 78,000 | 76,000 | ||||||||||
| other long term liabilities | ||||||||||||||
| share issue | ||||||||||||||
| interest | -2,000 | -5,000 | 15,000 | 55,000 | 46,907 | 13,000 | 25,000 | 19,000 | 21,000 | 13,000 | -65,000 | 5,000 | 1,000 | -142,000 |
| cash flow from financing | 840,000 | -488,000 | 2,170,000 | -1,222,848 | -3,729,770 | -1,267,000 | 2,745,000 | -1,939,000 | 2,985,000 | -1,845,000 | 6,274,000 | -2,719,000 | 4,311,000 | 11,421,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -1,000 | 2,000 | -6,000 | 6,000 | ||||||||||
| overdraft | -10,437 | 10,437 | ||||||||||||
| change in cash | -1,000 | 2,000 | 10,437 | -10,437 | -6,000 | 6,000 |
agfa healthcare uk limited Credit Report and Business Information
Agfa Healthcare Uk Limited Competitor Analysis
Perform a competitor analysis for agfa healthcare uk limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other mid companies, companies in CB1 area or any other competitors across 12 key performance metrics.
agfa healthcare uk limited Ownership
AGFA HEALTHCARE UK LIMITED group structure
Agfa Healthcare Uk Limited has 1 subsidiary company.
Ultimate parent company
AGFA GEVAERT NV
#0010875
2 parents
AGFA HEALTHCARE UK LIMITED
06317215
1 subsidiary
agfa healthcare uk limited directors
Agfa Healthcare Uk Limited currently has 2 directors. The longest serving directors include Mr Johannes Bossink (Nov 2022) and Mr Raf Peeters (Nov 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Johannes Bossink | England | 58 years | Nov 2022 | - | Director |
| Mr Raf Peeters | Belgium | 41 years | Nov 2023 | - | Director |
P&L
December 2022turnover
14.3m
+60%
operating profit
-547k
+46%
gross margin
26.6%
-51.8%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
12.1m
-0.03%
total assets
18.4m
+0.05%
cash
1k
0%
net assets
Total assets minus all liabilities
agfa healthcare uk limited company details
company number
06317215
Type
Private limited with Share Capital
industry
62090 - Other information technology and computer service activities
86900 - Other human health activities
incorporation date
July 2007
age
18
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2022
previous names
N/A
accountant
-
auditor
MHA MOORE AND SMALLEY
address
515 coldhams lane, cambridge, CB1 3JS
Bank
-
Legal Advisor
-
agfa healthcare uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to agfa healthcare uk limited.
agfa healthcare uk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AGFA HEALTHCARE UK LIMITED. This can take several minutes, an email will notify you when this has completed.
agfa healthcare uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
